Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death

Video Credit: Wochit
Published on May 23, 2020 - Duration: 00:26s

Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death

Business Insider reports that a coronavirus vaccine my not be ready until the end of 2021, according to Roche, the world's second-largest pharmaceutical company.

He explained "According to the most likely scenario, we will not have a vaccination before the end of next year." Instead, Severin Schwan, chief executive of Roche, says that the public could have access to antibody tests sooner.

An antibody test, which could be available as early as May, would determine whether someone has had the COVID-19 infection.

If so, they would have assumed ongoing immunity to the virus.

Schwan said that an antibody test is key to allowing businesses to reopen and for people to gradually return to normal life.


You are here

Related news from verified sources

The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to an increased risk...
on May 22, 2020 • Reuters India

The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to an increased risk...
on May 23, 2020 • Reuters India

The malaria drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to increased risk of death...
on May 22, 2020 • Reuters India

Related videos from verified sources

Study focuses on risks of breast cancer after pre-invasive disease 01:12
Video credit: ANI - Published on May 29, 2020 

Study: As COVID-19 Progresses, 40% May Not Show Any Symptoms At All 00:42
Video credit: Wochit - Published on May 27, 2020 

WHO Pauses Hydroxychloroquine Medical Trials for COVID-19 01:30
Video credit: Wibbitz Top Stories - Published on May 27, 2020 

You might like